What is the registration number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH?

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH is registered under USPTO registration number 4383440.

ACT

USPTO Trademark Record

ABANDONED

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH

Q: Who owns the ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark?

The ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark is owned by Albuquerque Clinical Trials.

Q: What class is the ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark registered in?

The ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH trademark is registered in Class 042 (Scientific, technology & SaaS services).

Q: What is the serial number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH?

The USPTO serial number for ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH is 85796707.

SN 85796707·Reg 4383440·Filed Dec 06, 2012

Owner Albuquerque Clinical Trials

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH (Serial No. 85796707), Registration No. 4383440, is a abandoned US trademark filed on Dec 06, 2012 by Albuquerque Clinical Trials. This trademark covers Class 042 (Scientific, technology & SaaS services).

Mark Intelligence

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH (Reg. #4383440) is an abandoned US trademark that was filed in 2012 but has since been abandoned. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Dec 06, 2012

SERIAL

85796707

REG#

4383440

REGISTERED

Aug 13, 2013

Owner

Applicant

Albuquerque Clinical Trials

Entity

Corporation

State

Address

801 Encino Place NE, Suite A-16, Albuquerque, NM, 87102

Country

Attorney

Law firm

ALBUQUERQUE CLINICAL TRIALS

Address

711 ENCINO PL NE, ALBUQUERQUE, NM 87102-2640, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusABANDONED

Filing DateDec 06, 2012

Serial Number85796707

Registration No.4383440

Registration DateAug 13, 2013

Status DateMar 20, 2020

Published for OppositionMay 28, 2013

Mark TypeDesign with words

Status DescriptionDead and cancelled, Section 8

Filing Signals

FILED

2012

YEARS AGO

14y

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Nov 30, 2004

First use in commerce: Nov 30, 2004

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

19 events

CANCELLED SEC. 8 (6-YR)

Mar 20, 2020

CANCELLED SEC. 8 (6-YR)

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Aug 13, 2018

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Apr 17, 2017

TEAS CHANGE OF CORRESPONDENCE RECEIVED

Mar 15, 2017

TEAS CHANGE OF CORRESPONDENCE RECEIVED

REGISTERED-PRINCIPAL REGISTER

Aug 13, 2013

REGISTERED-PRINCIPAL REGISTER

PUBLISHED FOR OPPOSITION

May 28, 2013

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

May 28, 2013

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

May 08, 2013

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

ASSIGNED TO LIE

Apr 19, 2013

ASSIGNED TO LIE

LAW OFFICE PUBLICATION REVIEW COMPLETED

Apr 19, 2013

LAW OFFICE PUBLICATION REVIEW COMPLETED

EXAMINERS AMENDMENT -WRITTEN

Mar 28, 2013

EXAMINERS AMENDMENT -WRITTEN

EXAMINERS AMENDMENT E-MAILED

Mar 28, 2013

EXAMINERS AMENDMENT E-MAILED

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

Mar 28, 2013

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

EXAMINER'S AMENDMENT ENTERED

Mar 28, 2013

EXAMINER'S AMENDMENT ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Mar 28, 2013

APPROVED FOR PUB - PRINCIPAL REGISTER

ASSIGNED TO EXAMINER

Mar 24, 2013

ASSIGNED TO EXAMINER

NOTICE OF DESIGN SEARCH CODE MAILED

Dec 19, 2012

NOTICE OF DESIGN SEARCH CODE MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Dec 18, 2012

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Dec 10, 2012

NEW APPLICATION ENTERED

ACT ALBUQUERQUE CLINICAL TRIALS A CENTER FOR CLINICAL RESEARCH

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks in Class 042 — Scientific, technology & SaaS services

Resources

Company